Radiomics and deep learning fusion model based on multiphasic CT for predicting HER2 expression status in bladder urothelial carcinoma: a multicenter study.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: 411 patients; tri-phasic CT radiomics and 2.5D/3D ResNet50 fusion against HER2 IHC, with independent internal and two-center external validation; external AUC 0.873. Retrospective proof of concept, not prospective treatment benefit.
Technology: Methods name the learned image/gene-expression model and its input-operation tied to the reported result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Methods name the learned image/gene-expression model and its input-operation tied to the reported result.
- Limitation / still unknown
- Independent test cohort(s) or assay validation reported as described in the reason; interpretation bounded to stated cohort.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://tau.amegroups.org/article/view/150131/html · https://europepmc.org/article/MED/41971125
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.